Weekly Roundup: Oct 5, 2018

Weekly Roundup: Oct 5, 2018

This week, Pfizer's Matthew Harold joins us to discuss the findings of his recent research study that reviewed national policies for rare diseases in the context of key patient needs. Presenter: Max Rex Contributor: Matthew Harold, International Developed Markets Public Affairs Lead, Pfizer

Duration: 15 min

Release Date:

Share part or all of the audio of this episode